Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Expression, Kew Group to Commercialize NGS Cancer Panel in Scandinavia

NEW YORK (GenomeWeb) – Genomic Expression and the Kew Group will collaborate to launch Kew's next-generation sequencing-based cancer panel in Scandinavia, the companies said this week.

Kew's CancerPlex assay uses Thermo Fisher's Ion Torrent PGM to analyze over 400 known cancer genes involved in initiation and progression.

The companies will use Kew's panel and Genomic Expression's sample evaluation and informatics technologies.

"Our united ability to bring large-scale oncology genomic profiling to Scandinavian cancer patients represents a dramatic improvement in current diagnostic options," Kew Group CEO Scott Schell said in a statement.

Genomic Expression CEO Gitte Pedersen added that "the comprehensive analysis of known actionable genes in the CancerPlex assay is immediately valuable for patients in selecting more effective treatments and avoiding treatments that don't prolong life."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.